A Study Evaluating the Safety and Efficacy of Lovo-cel in Severe Sickle Cell Disease

NCT02140554 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

54

Enrollment

INDUSTRY

Sponsor class

Conditions

Sickle Cell Disease

Interventions

GENETIC: lovo-cel

Sponsor

Genetix Biotherapeutics Inc.